Gland Pharma`s Generic Temsirolimus Receives Approval in US
AstraZeneca has decided to discontinue one of its midstage cancer drugs—mTOR inhibitor vistusertib—despite reporting encouraging clinical data earlier in the year.
Gland Pharma`s Generic Temsirolimus Receives Approval in US
Accord Healthcare's Generic Temsirolimus Receives Approval in US
Pfizer’s Oncology segment accounts for less than 20% of the company’s value, according to our estimates. For many other major pharma companies, their oncology portfolios are larger contributors to their top lines, and Pfizer has been looking to capitalize on opportunities in the space.
Diagnosed two years ago with HER 2 positive breast cancer, she was treated at the All India Institute of Medical Sciences (AIIMS). However, when it came to treatment Prabha’s son Chetan — the only earning member of the family with an approximate annual salary of ?3.5 lakh — could not afford to get his mother the Roche medicine trastuzumab that her condition needed. Her treatment would have costed Chetan at least ?8 lakh.
Novartis today announced results from a Phase III study showing Afinitor®* (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures associated with tuberous sclerosis complex (TSC) compared to placebo1. Patients in all treatment arms were also taking one to three anti-epileptic drugs (AEDs)1. The study, EXIST-3 (EXamining everolimus In a Study of TSC), is being presented during a plenary session at the 68th Annual Meeting of the American Academy of Neurology (AAN) (Abstract #32430, 9:00–11:00 a.m. PST)1.
Brazil has cut the import duty on three drugs that are used for kidney transplants and for treating lung and kidney cancer.nnThe reductions were made through CAMEX Resolution No. 120/2015, which was published in the Official Gazette on December 18, 2015.nnUnder the resolution, the import duty on basiliximab, a drug used in kidney transplants, was reduced from two percent to zero percent.